Arnold, C. J., Nakata, K., Hassan, A., Alderete, I., Aykun, N., Abraham, N., … Hartwig, M. G. (2025). Optimized Cellular Perfusate Increases Lung Viability Ex Vivo and Extends the Duration of Ex Vivo Lung Perfusion. In JOURNAL OF HEART AND LUNG TRANSPLANTATION (Vol. 44, pp. S728–S729).

Arnold, C. J., K. Nakata, A. Hassan, I. Alderete, N. Aykun, N. Abraham, C. John, et al. “Optimized Cellular Perfusate Increases Lung Viability Ex Vivo and Extends the Duration of Ex Vivo Lung Perfusion.” In JOURNAL OF HEART AND LUNG TRANSPLANTATION, 44:S728–29, 2025.

Arnold CJ, Nakata K, Hassan A, Alderete I, Aykun N, Abraham N, et al. Optimized Cellular Perfusate Increases Lung Viability Ex Vivo and Extends the Duration of Ex Vivo Lung Perfusion. In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2025. p. S728–9.

Arnold, C. J., et al. “Optimized Cellular Perfusate Increases Lung Viability Ex Vivo and Extends the Duration of Ex Vivo Lung Perfusion.” JOURNAL OF HEART AND LUNG TRANSPLANTATION, vol. 44, no. 4, 2025, pp. S728–29.

Arnold CJ, Nakata K, Hassan A, Alderete I, Aykun N, Abraham N, John C, Xiang Y, Kamaleswaran R, Hughes B, Barbas AS, Hartwig MG. Optimized Cellular Perfusate Increases Lung Viability Ex Vivo and Extends the Duration of Ex Vivo Lung Perfusion. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2025. p. S728–S729.